Abstract
Celiac disease may present as a cryptogenic liver disorder being found in 5–10% of patients with a persistent and cryptogenetic elevation of serum aminotransferase activity. In fact, a wide spectrum of liver injuries in children and adults may be related to CD and in particular: (1) a mild parenchymal damage characterised by absence of any clinical sign or symptom suggesting a chronic liver disease and by non-specific histological changes reversible on a gluten-free diet; (2) a chronic inflammatory liver injury of autoimmune mechanism, including autoimmune hepatitis, primary sclerosing cholangitis and primary biliary cirrhosis, that may lead to fibrosis and cirrhosis, generally unaffected by gluten withdrawal and necessitating an immunosuppressive treatment; (3) a severe liver failure potentially treatable by a gluten-free diet. Such different types of liver injuries may represent a spectrum of a same disorder where individual factors, such as genetic predisposition, precocity and duration of exposure to gluten may influence the reversibility of liver damage. A rigorous cross-checking for a asymptomatic liver damage in CD individuals and conversely, for CD in any cryptogenic liver disorder including end-stage liver failure is recommended.
Similar content being viewed by others
References
Pollock DJ. The liver in coeliac disease.Histopathology 1977; 1: 421–430.
Duggan JM, Duggan AE. Systematic review: The liver in celiac disease.Aliment Pharmacol Ther 2005; 21: 515–518.
Cassagnou M, Boruchowicz A, Guillemot Fet al. Hepatic steatosis revealing celiac disease: a case complicated by transitory liver failure.Am J Gastroenterol 1996; 91: 1291–1292.
Austin A, Campbell E, Lane P, Elias E. Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anti-cardiolipin antibody.Gut 2004; 53: 1032–1034
Hagander B, Brandt L, Sjolund K, Berg NO, Nordén Å Stenstam M. Hepatic injury in adult coeliac disease.Lancet 1977; 2: 270–272.
Bonamico M, Pitzalis G. Culasso Fet al. A. Il danno epatico nella malattia celiaca del bambino.Minerva Pediatr 1986; 38: 959–962.
Leonardi S, Bottaro G, Patané R, Musumeci S. Hypetransaminasemia as the first symptom in infant celiac disease.J Pediatr Gastroenterol Nutr 1990; 11: 404–406.
Maggiore G, De Giacomo C, Scotta MS, Sessa F. Celiac disease presenting as chronic hepatitis in girl.J Pediatr Gastroenterol Nutr 1986; 5: 501–503.
Vajro P, Fontanella A, Mayer Met al. Elevated Serum minotransferases activity as an early manifestation of glutensensitive enteropathy.J Pediatr 1993; 122: 416–419.
Volta U, De Franceschi L, Lari F, Molinaro N, Zoli M, Bianchi FB. Coeliac disease hidden by cryptogenic hypertransaminasemia.Lancet 1998; 352: 26–29.
Bardella MT, Vecchi M, Conte Det al. Chronic unexplained hypertransaminasemia may be caused by occult celiac disease.Hepatology 1999; 29: 654–657.
Maggiore G, Caprai S. The Liver in celiac disease.J Pediatr Gastroenterol Nutr 2003; 37: 117–119.
Demir H, Yüce A, Caglar Met al. Cirrhosis in children with celiac disease.J Clin Gastroenterol 2005; 39: 630–633.
Lindgren S, Sjoberg K, Eriksson S. Unsuspected celiac disease in chronic cryptogenic liver disease.Scand J Gastroenterol 1994; 29: 661–664.
Volta U, De Franceschi L, Molinaro Net al. Frequency and significance of anti-gliadin and anti-endomisial antibodies in autoimmune hepatitis.Dig Dis Sci 1998; 43: 2190–2195.
Francavilla R, Castellaneta SP, Davis T, Hadzic N, Mieli-Vergani G. Coeliac disease in children with autoimmune hepatitis.Dig Liver Dis 2001; 33: 624 (abstract)
Ventura A, Magazzu' G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease.Gastroenterology 1999; 117: 297–303.
Lawson A, West J, Aithal GP, Logan RF. Autoimmune cholestatic liver disease in people with celiac disease: a population-based study of their association.Aliment Pharmacol Ther 2005; 21: 401–405.
Jacobsen MB, Fausa O, Elgjo K, Schrumpf E. Hepatic lesions in adult coeliac disease.Scand J Gastroenterol 1990; 25: 656–662.
Davison S. Coeliac disease and liver dysfunction.Arch Dis Child 2002; 87: 293–296.
Korponay-Szabo IR, Halttunen T, Szalai Zet al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies.Gut 2004; 53: 641–648.
Stevens FM, McLoughlin RM. Is coeliac disease a potentially treatable cause of liver failure?Eur J Gastroenterol Hepatol 2005; 17: 1015–1017.
Kaukinen K, Halme L, Collin Pet al. K. Coeliac disease in patients with severe liver disease: gluten free diet may reverse hepatic failure.Gastroenterology 2002; 122: 881–888.
Ojetti V, Fini I, Zileri Dal Verme L, Migneco A, Pola P, Gasbarrini A. Acute cryptogenic liver failure in an untreated coeliac patient: a case report.Eur J Gastroenterol Hepatol 2005; 17: 1119–1121.
Pavone P, Guttadauria S, Leonardi Set al. Liver transplantation in a child with celiac disease.J Gastroenterol Hepatol 2005; 20: 956–960.
Villalta D, Crovatto M, Stella S, Tonutti E, Tozzoli R, Bizzarro N. False positive reactions for IgA and IgG anti-tissue transglutaminase antibodies in liver cirrhosis are common and method-dependent.Clin Chim Acta 2005; 356: 102–109.
Lo Iacono O, Petta S, Venezia Get al. Anti-tissue transglutaminase antibodies in patients with abnormal liver tests: is it always celiac disease?Am J Gastroenterol 2005; 100: 2472–2477.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maggiore, G., Caprai, S. Liver involvement in celiac disease. Indian J Pediatr 73, 809–811 (2006). https://doi.org/10.1007/BF02790391
Issue Date:
DOI: https://doi.org/10.1007/BF02790391